0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Research Report 2026
Published Date: 2026-04-23
|
Report Code: QYRE-Auto-18G13123
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Contract Sales Outsourcing CSO Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Research Report 2026

Code: QYRE-Auto-18G13123
Report
2026-04-23
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Contract Sales Outsourcing (CSO) Market Size

The global Pharmaceutical Contract Sales Outsourcing (CSO) market was valued at US$ 9236 million in 2025 and is anticipated to reach US$ 14810 million by 2032, at a CAGR of 7.1% from 2026 to 2032.

Pharmaceutical Contract Sales Outsourcing (CSO) Market

Pharmaceutical Contract Sales Outsourcing (CSO) Market

Pharmaceutical Contract Sales Outsourcing (CSO), also known as Contract Sales Organization (CSO),means an Entity commonly and primarily known as a "contract sales organization" that is engaged primarily in the business of promoting products for third parties and is not, and is not a direct or indirect affiliate of, an entity commonly and primarily known as a "pharmaceutical", "biopharmaceutical" or "biotechnology" company; and (2) "Contract Sales Arrangement" shall mean an arrangement (that is terminable by the Company within three years without payment or penalty) between the Company and a Contract Sales Organization under which such Contract Sales Organization (A) would promote (and would only be granted such rights as are necessary to promote) a Company Pharmaceutical Product for a fee (which may be fixed or based upon a percentage of revenues or otherwise) but (B) would not be granted any research, development, manufacturing, sublicensing or other rights with respect to such Company Pharmaceutical Product or with respect to any Intellectual Property underlying or related to such Company Pharmaceutical Product except as necessary for the purpose of clause "(A)".
The Pharmaceutical Contract Sales Outsourcing (CSO) market covers Personal Promotion, Non-personal Promotion, Others, etc. The typical players include IQVIA, PHOENIX Group, Amplity Health, Ashfield Engage (Inizio), Syneos Health, EVERSANA, CMIC Group, EPS Corporation, etc.
Global key players of pharmaceutical contract sales outsourcing include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, etc. The top five players hold a share over 40%.
This report delivers a comprehensive overview of the global Pharmaceutical Contract Sales Outsourcing (CSO) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Contract Sales Outsourcing (CSO). The Pharmaceutical Contract Sales Outsourcing (CSO) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Contract Sales Outsourcing (CSO) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Contract Sales Outsourcing (CSO) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharmaceutical Contract Sales Outsourcing (CSO) Market Report

Report Metric Details
Report Name Pharmaceutical Contract Sales Outsourcing (CSO) Market
Accounted market size in 2025 US$ 9236 million
Forecasted market size in 2032 US$ 14810 million
CAGR 7.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Personal Promotion
  • Non-personal Promotion
  • Others
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health, EPS Corporation, Uniphar Group, CMIC Group, SciClone Pharmaceuticals, China Pioneer Pharma, Promoveo Health, CSO Pharmitalia, GTS Solution, QFR Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Pharmaceutical Contract Sales Outsourcing (CSO) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Contract Sales Outsourcing (CSO) Market growing?

Ans: The Pharmaceutical Contract Sales Outsourcing (CSO) Market witnessing a CAGR of 7.1% during the forecast period 2026-2032.

What is the Pharmaceutical Contract Sales Outsourcing (CSO) Market size in 2032?

Ans: The Pharmaceutical Contract Sales Outsourcing (CSO) Market size in 2032 will be US$ 14810 million.

What is the market share of major companies in Pharmaceutical Contract Sales Outsourcing (CSO) Market?

Ans: The top five players hold a share over 40%.

Who are the main players in the Pharmaceutical Contract Sales Outsourcing (CSO) Market report?

Ans: The main players in the Pharmaceutical Contract Sales Outsourcing (CSO) Market are China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health, EPS Corporation, Uniphar Group, CMIC Group, SciClone Pharmaceuticals, China Pioneer Pharma, Promoveo Health, CSO Pharmitalia, GTS Solution, QFR Solutions

What are the Application segmentation covered in the Pharmaceutical Contract Sales Outsourcing (CSO) Market report?

Ans: The Applications covered in the Pharmaceutical Contract Sales Outsourcing (CSO) Market report are Pharmaceutical Company, Biotechnology Company, Generic Company, Others

What are the Type segmentation covered in the Pharmaceutical Contract Sales Outsourcing (CSO) Market report?

Ans: The Types covered in the Pharmaceutical Contract Sales Outsourcing (CSO) Market report are Personal Promotion, Non-personal Promotion, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Personal Promotion
1.2.3 Non-personal Promotion
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Perspective (2021–2032)
2.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Region (2021–2026)
2.2.3 Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Region (2027–2032)
2.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Dynamics
2.3.1 Pharmaceutical Contract Sales Outsourcing (CSO) Industry Trends
2.3.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
2.3.3 Pharmaceutical Contract Sales Outsourcing (CSO) Market Challenges
2.3.4 Pharmaceutical Contract Sales Outsourcing (CSO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Revenue (2021–2026)
3.1.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue
3.4 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue in 2025
3.5 Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO) Head Offices and Areas Served
3.6 Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Products and Applications
3.7 Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharmaceutical Contract Sales Outsourcing (CSO) Breakdown Data by Type
4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Type (2021–2026)
4.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Type (2027–2032)
5 Pharmaceutical Contract Sales Outsourcing (CSO) Breakdown Data by Application
5.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Historic Market Size by Application (2021–2026)
5.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2021–2032)
6.2 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2021–2026)
6.4 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2021–2032)
7.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2021–2026)
7.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2021–2032)
8.2 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2021–2032)
9.2 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2021–2026)
9.4 Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (2021–2032)
10.2 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 China Medical System (CMS)
11.1.1 China Medical System (CMS) Company Details
11.1.2 China Medical System (CMS) Business Overview
11.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.1.4 China Medical System (CMS) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.1.5 China Medical System (CMS) Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.2.4 IQVIA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.2.5 IQVIA Recent Development
11.3 PHOENIX Group
11.3.1 PHOENIX Group Company Details
11.3.2 PHOENIX Group Business Overview
11.3.3 PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.3.4 PHOENIX Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.3.5 PHOENIX Group Recent Development
11.4 EVERSANA
11.4.1 EVERSANA Company Details
11.4.2 EVERSANA Business Overview
11.4.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.4.4 EVERSANA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.4.5 EVERSANA Recent Development
11.5 Ashfield Engage (Inizio)
11.5.1 Ashfield Engage (Inizio) Company Details
11.5.2 Ashfield Engage (Inizio) Business Overview
11.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.5.4 Ashfield Engage (Inizio) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.5.5 Ashfield Engage (Inizio) Recent Development
11.6 Amplity Health
11.6.1 Amplity Health Company Details
11.6.2 Amplity Health Business Overview
11.6.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.6.4 Amplity Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.6.5 Amplity Health Recent Development
11.7 Sinco Pharma
11.7.1 Sinco Pharma Company Details
11.7.2 Sinco Pharma Business Overview
11.7.3 Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.7.4 Sinco Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.7.5 Sinco Pharma Recent Development
11.8 Syneos Health
11.8.1 Syneos Health Company Details
11.8.2 Syneos Health Business Overview
11.8.3 Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.8.4 Syneos Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.8.5 Syneos Health Recent Development
11.9 EPS Corporation
11.9.1 EPS Corporation Company Details
11.9.2 EPS Corporation Business Overview
11.9.3 EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.9.4 EPS Corporation Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.9.5 EPS Corporation Recent Development
11.10 Uniphar Group
11.10.1 Uniphar Group Company Details
11.10.2 Uniphar Group Business Overview
11.10.3 Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.10.4 Uniphar Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.10.5 Uniphar Group Recent Development
11.11 CMIC Group
11.11.1 CMIC Group Company Details
11.11.2 CMIC Group Business Overview
11.11.3 CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.11.4 CMIC Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.11.5 CMIC Group Recent Development
11.12 SciClone Pharmaceuticals
11.12.1 SciClone Pharmaceuticals Company Details
11.12.2 SciClone Pharmaceuticals Business Overview
11.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.12.4 SciClone Pharmaceuticals Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.12.5 SciClone Pharmaceuticals Recent Development
11.13 China Pioneer Pharma
11.13.1 China Pioneer Pharma Company Details
11.13.2 China Pioneer Pharma Business Overview
11.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.13.4 China Pioneer Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.13.5 China Pioneer Pharma Recent Development
11.14 Promoveo Health
11.14.1 Promoveo Health Company Details
11.14.2 Promoveo Health Business Overview
11.14.3 Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.14.4 Promoveo Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.14.5 Promoveo Health Recent Development
11.15 CSO Pharmitalia
11.15.1 CSO Pharmitalia Company Details
11.15.2 CSO Pharmitalia Business Overview
11.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.15.4 CSO Pharmitalia Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.15.5 CSO Pharmitalia Recent Development
11.16 GTS Solution
11.16.1 GTS Solution Company Details
11.16.2 GTS Solution Business Overview
11.16.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.16.4 GTS Solution Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.16.5 GTS Solution Recent Development
11.17 QFR Solutions
11.17.1 QFR Solutions Company Details
11.17.2 QFR Solutions Business Overview
11.17.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Introduction
11.17.4 QFR Solutions Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
11.17.5 QFR Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Personal Promotion
 Table 3. Key Players of Non-personal Promotion
 Table 4. Key Players of Others
 Table 5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Region (2021–2026)
 Table 9. Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Region (2027–2032)
 Table 11. Pharmaceutical Contract Sales Outsourcing (CSO) Market Trends
 Table 12. Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
 Table 13. Pharmaceutical Contract Sales Outsourcing (CSO) Market Challenges
 Table 14. Pharmaceutical Contract Sales Outsourcing (CSO) Market Restraints
 Table 15. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Players (2021–2026)
 Table 17. Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, 2025
 Table 18. Ranking of Global Top Pharmaceutical Contract Sales Outsourcing (CSO) Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Headquarters and Area Served
 Table 21. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Products and Applications
 Table 22. Global Key Players of Pharmaceutical Contract Sales Outsourcing (CSO), Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Type (2021–2026)
 Table 26. Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Type (2027–2032)
 Table 28. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Application (2021–2026)
 Table 30. Global Pharmaceutical Contract Sales Outsourcing (CSO) Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Application (2027–2032)
 Table 32. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country (US$ Million), 2027–2032
 Table 47. China Medical System (CMS) Company Details
 Table 48. China Medical System (CMS) Business Overview
 Table 49. China Medical System (CMS) Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 50. China Medical System (CMS) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 51. China Medical System (CMS) Recent Development
 Table 52. IQVIA Company Details
 Table 53. IQVIA Business Overview
 Table 54. IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 55. IQVIA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 56. IQVIA Recent Development
 Table 57. PHOENIX Group Company Details
 Table 58. PHOENIX Group Business Overview
 Table 59. PHOENIX Group Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 60. PHOENIX Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 61. PHOENIX Group Recent Development
 Table 62. EVERSANA Company Details
 Table 63. EVERSANA Business Overview
 Table 64. EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 65. EVERSANA Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 66. EVERSANA Recent Development
 Table 67. Ashfield Engage (Inizio) Company Details
 Table 68. Ashfield Engage (Inizio) Business Overview
 Table 69. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 70. Ashfield Engage (Inizio) Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 71. Ashfield Engage (Inizio) Recent Development
 Table 72. Amplity Health Company Details
 Table 73. Amplity Health Business Overview
 Table 74. Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 75. Amplity Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 76. Amplity Health Recent Development
 Table 77. Sinco Pharma Company Details
 Table 78. Sinco Pharma Business Overview
 Table 79. Sinco Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 80. Sinco Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 81. Sinco Pharma Recent Development
 Table 82. Syneos Health Company Details
 Table 83. Syneos Health Business Overview
 Table 84. Syneos Health Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 85. Syneos Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 86. Syneos Health Recent Development
 Table 87. EPS Corporation Company Details
 Table 88. EPS Corporation Business Overview
 Table 89. EPS Corporation Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 90. EPS Corporation Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 91. EPS Corporation Recent Development
 Table 92. Uniphar Group Company Details
 Table 93. Uniphar Group Business Overview
 Table 94. Uniphar Group Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 95. Uniphar Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 96. Uniphar Group Recent Development
 Table 97. CMIC Group Company Details
 Table 98. CMIC Group Business Overview
 Table 99. CMIC Group Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 100. CMIC Group Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 101. CMIC Group Recent Development
 Table 102. SciClone Pharmaceuticals Company Details
 Table 103. SciClone Pharmaceuticals Business Overview
 Table 104. SciClone Pharmaceuticals Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 105. SciClone Pharmaceuticals Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 106. SciClone Pharmaceuticals Recent Development
 Table 107. China Pioneer Pharma Company Details
 Table 108. China Pioneer Pharma Business Overview
 Table 109. China Pioneer Pharma Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 110. China Pioneer Pharma Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 111. China Pioneer Pharma Recent Development
 Table 112. Promoveo Health Company Details
 Table 113. Promoveo Health Business Overview
 Table 114. Promoveo Health Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 115. Promoveo Health Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 116. Promoveo Health Recent Development
 Table 117. CSO Pharmitalia Company Details
 Table 118. CSO Pharmitalia Business Overview
 Table 119. CSO Pharmitalia Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 120. CSO Pharmitalia Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 121. CSO Pharmitalia Recent Development
 Table 122. GTS Solution Company Details
 Table 123. GTS Solution Business Overview
 Table 124. GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 125. GTS Solution Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 126. GTS Solution Recent Development
 Table 127. QFR Solutions Company Details
 Table 128. QFR Solutions Business Overview
 Table 129. QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product
 Table 130. QFR Solutions Revenue in Pharmaceutical Contract Sales Outsourcing (CSO) Business (US$ Million), 2021–2026
 Table 131. QFR Solutions Recent Development
 Table 132. Research Programs/Design for This Report
 Table 133. Key Data Information from Secondary Sources
 Table 134. Key Data Information from Primary Sources
 Table 135. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Contract Sales Outsourcing (CSO) Picture
 Figure 2. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Type: 2025 vs 2032
 Figure 4. Personal Promotion Features
 Figure 5. Non-personal Promotion Features
 Figure 6. Others Features
 Figure 7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Application: 2025 vs 2032
 Figure 9. Pharmaceutical Company Case Studies
 Figure 10. Biotechnology Company Case Studies
 Figure 11. Generic Company Case Studies
 Figure 12. Others Case Studies
 Figure 13. Pharmaceutical Contract Sales Outsourcing (CSO) Report Years Considered
 Figure 14. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Region: 2025 vs 2032
 Figure 17. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Players in 2025
 Figure 18. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Sales Outsourcing (CSO) Revenue in 2025
 Figure 20. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Country (2021–2032)
 Figure 22. United States Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Country (2021–2032)
 Figure 26. Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Region (2021–2032)
 Figure 34. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Country (2021–2032)
 Figure 42. Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Share by Country (2021–2032)
 Figure 46. Israel Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Pharmaceutical Contract Sales Outsourcing (CSO) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. China Medical System (CMS) Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 50. IQVIA Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 51. PHOENIX Group Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 52. EVERSANA Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 53. Ashfield Engage (Inizio) Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 54. Amplity Health Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 55. Sinco Pharma Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 56. Syneos Health Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 57. EPS Corporation Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 58. Uniphar Group Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 59. CMIC Group Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 60. SciClone Pharmaceuticals Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 61. China Pioneer Pharma Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 62. Promoveo Health Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 63. CSO Pharmitalia Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 64. GTS Solution Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 65. QFR Solutions Revenue Growth Rate in Pharmaceutical Contract Sales Outsourcing (CSO) Business (2021–2026)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS